Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2016 1
2017 2
2018 1
2019 2
2021 1
2022 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Genetic predisposition to male breast cancer in Poland.
Szwiec M, Tomiczek-Szwiec J, Kluźniak W, Wokołorczyk D, Osowiecka K, Sibilski R, Wachowiak M, Gronwald J, Gronwald H, Lubiński J, Cybulski C, Narod SA, Huzarski T. Szwiec M, et al. Among authors: sibilski r. BMC Cancer. 2021 Aug 30;21(1):975. doi: 10.1186/s12885-021-08718-3. BMC Cancer. 2021. PMID: 34461861 Free PMC article.
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Tomiczek-Szwiec J, Szwiec M, Falco M, Cybulski C, Wokolorczyk D, Jakubowska A, Gronwald J, Stawicka M, Godlewski D, Kilar E, Marczyk E, Siołek M, Wiśniowski R, Haus O, Sibilski R, Bodnar L, Sun P, Narod SA, Lubinski J, Huzarski T; Polish Breast Cancer Consortium. Tomiczek-Szwiec J, et al. Among authors: sibilski r. Br J Cancer. 2022 Jul;127(1):84-91. doi: 10.1038/s41416-022-01770-1. Epub 2022 Mar 7. Br J Cancer. 2022. PMID: 35256754 Free PMC article.
Survival from breast cancer in patients with CHEK2 mutations.
Huzarski T, Cybulski C, Wokolorczyk D, Jakubowska A, Byrski T, Gronwald J, Domagała P, Szwiec M, Godlewski D, Kilar E, Marczyk E, Siołek M, Wiśniowski R, Janiszewska H, Surdyka D, Sibilski R, Sun P, Lubiński J, Narod SA. Huzarski T, et al. Among authors: sibilski r. Breast Cancer Res Treat. 2014 Apr;144(2):397-403. doi: 10.1007/s10549-014-2865-2. Epub 2014 Feb 21. Breast Cancer Res Treat. 2014. PMID: 24557336
Inherited variants in XRCC2 and the risk of breast cancer.
Kluźniak W, Wokołorczyk D, Rusak B, Huzarski T, Gronwald J, Stempa K, Rudnicka H, Kashyap A, Dębniak T, Jakubowska A, Lener M, Szwiec M, Tomiczek-Szwiec J, Jarkiewicz-Tretyn J, Cechowska M, Domagała P, Szymiczek A, Bagherzadeh M, Lubiński J, Narod SA, Akbari MR, Cybulski C; Polish Hereditary Breast Cancer Consortium. Kluźniak W, et al. Breast Cancer Res Treat. 2019 Dec;178(3):657-663. doi: 10.1007/s10549-019-05415-5. Epub 2019 Aug 28. Breast Cancer Res Treat. 2019. PMID: 31463769 Free PMC article.
Predictors of survival for breast cancer patients with a BRCA1 mutation.
Narod SA, Huzarski T, Gronwald J, Byrski T, Marczyk E, Cybulski C, Szwiec M, Wisniowski R, Birkenfeld B, Kilar E, Sibilski R, Sun P, Lubinski J. Narod SA, et al. Among authors: sibilski r. Breast Cancer Res Treat. 2018 Apr;168(2):513-521. doi: 10.1007/s10549-017-4605-x. Epub 2017 Dec 15. Breast Cancer Res Treat. 2018. PMID: 29247441
Allelic modification of breast cancer risk in women with an NBN mutation.
Rusak B, Kluźniak W, Wokołorczyk D, Stempa K, Kashyap A, Rudnicka H, Gronwald J, Huzarski T, Dębniak T, Jakubowska A, Szwiec M, Akbari MR, Narod SA, Lubiński J, Cybulski C; Polish Hereditary Breast Cancer Consortium. Rusak B, et al. Breast Cancer Res Treat. 2019 Nov;178(2):427-431. doi: 10.1007/s10549-019-05391-w. Epub 2019 Aug 13. Breast Cancer Res Treat. 2019. PMID: 31410679
Clinical characteristics of breast cancer in patients with an NBS1 mutation.
Huzarski T, Cybulski C, Jakubowska A, Byrski T, Gronwald J, Domagała P, Szwiec M, Godlewski D, Kilar E, Marczyk E, Siołek M, Gorski B, Wiśniowski R, Janiszewska H, Surdyka D, Sibilski R, Sun P, Narod SA, Lubiński J; Polish Breast Cancer Consortium. Huzarski T, et al. Among authors: sibilski r. Breast Cancer Res Treat. 2013 Oct;141(3):471-6. doi: 10.1007/s10549-013-2692-x. Epub 2013 Sep 27. Breast Cancer Res Treat. 2013. PMID: 24072268
Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis.
Cybulski C, Kluźniak W, Huzarski T, Wokołorczyk D, Kashyap A, Jakubowska A, Szwiec M, Byrski T, Dębniak T, Górski B, Sopik V, Akbari MR, Sun P, Gronwald J, Narod SA, Lubiński J; Polish Hereditary Breast Cancer Consortium. Cybulski C, et al. Lancet Oncol. 2015 Jun;16(6):638-44. doi: 10.1016/S1470-2045(15)70142-7. Epub 2015 May 7. Lancet Oncol. 2015. PMID: 25959805
The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients.
Huzarski T, Byrski T, Gronwald J, Cybulski C, Oszurek O, Szwiec M, Gugała K, Stawicka M, Morawiec Z, Mierzwa T, Falco M, Janiszewska H, Kilar E, Marczyk E, Kozak-Klonowska B, Siołek M, Surdyka D, Wiśniowski R, Posmyk M, Domagała P, Sun P, Lubiński J, Narod SA; Polish Breast Cancer Consortium. Huzarski T, et al. Breast Cancer Res Treat. 2016 Apr;156(2):371-8. doi: 10.1007/s10549-016-3749-4. Epub 2016 Mar 17. Breast Cancer Res Treat. 2016. PMID: 26983446
11 results